LeonaBio, Inc.

Healthcare · Biotechnology · United States

Last price 4.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 46.54M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company’s lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clini...